Clinical Trials · NCT02055014
Randomisation to Endobarrier Alone Versus With Incretin Analogue in SustainEd Diabesity (REVISE-Diabesity)
- Phase
- Phase 4
- Recruitment status
- Unknown
- Sponsor
- Sandwell & West Birmingham Hospitals NHS Trust
- Enrollment
- 72
- Start date
- Jul 2013
- Locations
- 4 sites, United Kingdom
- Primary endpoint
- Glycated haemoglobin (HbA1c)